Evidence map›Paper›PMID 41754509›Full record

ArticleViruses2026

A Bovine Cell Line Resistant to Japanese Encephalitis Virus Entry but Permissive to Post-Entry Replication.

Sang-Im Yun, Young-Min Lee

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sang-Im YunDepartment of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Natural Resources, Utah State University, Logan, UT 84322, USA.
Young-Min LeeDepartment of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Natural Resources, Utah State University, Logan, UT 84322, USA.ORCID 0000-0002-3974-3405

Funding

A Single-Dose Long-Lasting Live-Attenuated Chimeric Vaccine Candidate Against the Emerging Tick-Borne Kyasanur Forest DiseaseR01AI187430 · NIAID · UTAH STATE UNIVERSITY · PI Young-Min Lee · 2025 to 2026
$688k
NIAID NIH HHS R01 AI187430NIH HHS 1R01AI187430-01Utah Agricultural Experiment Station UTA01655
6 · The paper itself

Abstract

Japanese encephalitis virus (JEV) is a mosquito-borne zoonotic orthoflavivirus that poses a significant global health threat. It causes severe neuroinflammatory disease in humans and reproductive failure in swine. Because of the broad host range and cell tropism of JEV, identifying animal cell lines resistant to infection has been a persistent challenge. In this study, we demonstrate that Madin-Darby bovine kidney (MDBK) cells are resistant to JEV infection yet remain fully permissive to viral replication when transfected with viral genomic RNA. Using immunoblotting, immunofluorescence, and flow cytometry, we show that MDBK cells, unlike the highly susceptible baby hamster kidney (BHK-21) cells used as controls, do not support viral entry but sustain all post-entry stages of the replication cycle. Further investigation confirmed that MDBK cells possess a functional clathrin-mediated endocytic pathway, as evidenced by their susceptibility to bovine viral diarrhea virus, which relies on clathrin-dependent endocytosis for host cell entry. These findings establish MDBK cells as a nonsusceptible cell line for JEV entry despite intact endocytic function, providing a valuable platform for studying virus-host cell interactions and for identifying and validating host cell entry factors, a major challenge in JEV research.

Indexed as

Encephalitis Virus, JapaneseVirus InternalizationVirus ReplicationAnimalsCattleCell LineEncephalitis, JapaneseEndocytosisentryflavivirusinfectionJapanese encephalitis virusnonsusceptibleorthoflaviviruspost-entryreplicationsusceptible

Identifiers

PMID41754509
PMCPMC12945126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.